Biote CORP Form 4 insider transactions

Biote Corp. CEO Bret Christensen reports purchasing 37,595 shares of Class A Common Stock at an average price of $3.87 on March 17, 2025.

Director Stephen Mark Cone of Biote Corp. [BTMD] acquired 38,104 shares of Class A Common Stock at an average price of $3.88 on March 17, 2025, increasing his total holdings to 160,829 shares.

Director Marc D. Beer reports purchasing 107,794 shares of Biote Corp. Class A Common Stock at a weighted average price of $3.87.

Guines LLC and Richard Barrera report acquiring additional shares of biote Corp. (BTMD) common stock through a series of open market purchases, increasing their beneficial ownership.

Bret Christensen, CEO of Biote Corp., reports the acquisition of 1,500,000 employee stock options with an exercise price of $4.37, vesting over time.

Robert Charles Peterson, CFO of biote Corp., sold 32,874 shares of Class A Common Stock on September 9, 2024, at a weighted average price of $6.2009.

Robert Peterson, CFO of Biote Corp., reports the acquisition and disposal of Class A Common Stock on July 8th and 9th, 2024.

Debra L. Morris, a director of Biote Corp., amended a previous Form 4 filing to accurately reflect the acquisition of 11,045 Deferred Settlement Restricted Stock Units (RSUs) on May 21, 2024.

Director Dana Lynn Jacoby reports acquisition and disposal of Biote Corp. stock and derivative securities.

Director Steven J. Heyer acquired stock options in Biote Corp. on May 21, 2024.

Director Debra L. Morris reports acquisition and disposal of Biote Corp. Class A Common Stock and Restricted Stock Units (RSUs).

Director Stephen Mark Cone reports acquisition of stock options and restricted stock units in Biote Corp.

Director Andrew R. Heyer reports acquisition of stock options and restricted stock units in Biote Corp.

Biote Corp.'s CEO, Teresa Sue Weber, reports acquiring 777,083 shares through an employee stock option on April 1, 2024.

Mary Elizabeth Conlon, General Counsel of Biote Corp., reports acquisition of stock options.

Director Marc D. Beer acquired stock options for 543,958 shares of Biote Corp. Class A Common Stock on April 1, 2024.